Member Info for Dibs61

unv - expect to hear plans to scale up and extend capacity in the next year. It�s clear that they will have to because the market demand will go far beyond 2.5m kits pa (IMO based on research) That�s of course if they don�t get bought out. Which is more likely than ever now.

unv - soul and feeling? Honestly mate if you are falling in and out of love with stocks then that is absolutely fatal to making rational investment decisions. Fatal. Decisions should be made dispassionate and based solely on the investment case. Is it there or is it not? I have to say I totally disagree with your thinking. The investment case here is more convincing than ever. Patience here will be handsomely rewarded. If you have lost patience then sell and find a better opportunity elsewhere. ATB and always DYOR

World has moved on? Product has less value? Are you being serious? I think it sounds like you�ve moved on mate lol

Visitect CD4 at last CE marked! Massive transformative development for this company. Initial sales not big but in 12 mths time we will see significant unmet demand being met and this companies SP catapulted to another level

Someone�s throwing in the towel. Investing is a game of patience and it is only the patient that are rewarded ultimately Nothing has changed. I am staying the course.

Taser - lol jolly will always pop up with these kind of posts when he�s uninvested but potentially interested. Roughly translated the price he usually quotes is the price he wants .... or less ;) Pinch of salt

Oh I guess this explains the recent soggy SP performance. This had been high on my watchlist for 2018 possible investment but I think I will continue to keep my powder dry! If my maths are correct this loan note conversion is equivalent to a whopping 50% dilution!! AND the conversion price is only 8p. Oh dear. Not good.

Bought in on her behalf. Cannot continue to ignore the series of positive announcements in the past couple of months. Get the sense this is gaining traction on fundamentals but the market hasn�t yet caught up. Imho

Whoa Tiger.... steady on you seem a bit impulsive :)

I�d agree with this. 50/50 chance I�d say but decent recovery for next year if they can finally deliver on a series of promises

Nice. Might produce a tick up eventually then. What�s your take on ODX prospects? Obviously you must be bullish but what is it that attracted you?

To be clever in hindsight. I�m waiting for 4p and I�m pretty sure I�m going to get it

Bio - that�s good to hear from my pov. Bid is currently 19.25 to 19.55 depending on order size

https://www.constructionnews.co.uk/markets/sectors/housing/budget-london-politicians-demand-modular-housing-cash/10025429.article

Yep certainly looks like it. �10k�s worth. Expecting this to resume its rise again soon. Hopefully not before I�ve added further.

The market got it spot on with this one. My favourite quote : The SP always tells you a story. And the market never believed in a win here with the sp languishing for so long and now a good 30% or so cheaper. Probably not even worth a punt at this price.

Exactly! Why would you set up an entire training site/operation for just A HUNDRED students a YEAR. That�s barely two students PER WEEK. What a joke these muppets are. And we know what this is really about. An attempt at a pre-placing pump on the SP. Shameful

Boy they pick �em don�t they! (Ruffer I mean)

Four weeks ago in the trading update: "Visitect� CD4 We have successfully manufactured bulk components for three validation batches of Visitect�CD4 which have passed QC testing at external sites and have now been assembled into devices. The first two batches of assembled devices have passed final QC testing with external testing. A third batch will begin external testing imminently. We have started using these validation batches to verify performance and this programme of testing is about 50% complete. External performance evaluations are underway at two UK hospital sites and we expect these to be completed within the next few weeks. The external performance evaluation in India is now complete and the data is being fully analysed with performance as expected on an initial review of the data. We therefore remain confident in our ability to CE-Mark the test before the end of the calendar year." In three and a half weeks time we will find out whether the above expectations have come to pass. Final confirmation of CD4 commercialisation SHOULD lift the SP. Clearly they will need to then gain sales traction but I cannot see a problem there because we know there is significant unmet demand.

Expecting announcements that will be highly positive for ASH and their majority owned partner F1 Modular This is a company with a very promising future DYOR